Australian Pathology Stocks Rise Amid Omicron Worries -- Market Talk
Australian Pathology Stocks Rise Amid Omicron Worries -- Market Talk
0345 GMT - Shares in Australian pathology firms Sonic Healthcare and Healius are higher even as worries over the impact of the Omicron coronavirus variant unsettle the local equities market. Shares in Sonic and Healius, both of which provide lab testing among their services, are up by 2.5% and 3.1% respectively despite the S&P/ASX 200 laboring to recover its early losses. The gains echo those of earlier this year, when Sonic and Healius shares each put on about 30% over three months as Covid-19's Delta variant spread across Australia and lifted demand for testing services. (stuart.condie@wsj.com; @StuartLCondie)
0345GMT-澳大利亚病理公司Sonic Healthcare和Healius的股价上涨，尽管对Omicron冠状病毒变体影响的担忧扰乱了当地股市。Sonic和Healius的股价分别上涨了2.5%和3.1%，尽管S&P/ASX 200指数正在努力收复早先的失地。Sonic和Healius的服务都提供实验室检测。这一涨幅呼应了今年早些时候的情况，当时随着新冠肺炎的Delta变体在澳大利亚蔓延，提振了对检测服务的需求，Sonic和Healius的股价在三个月内分别上涨了约30%。(stuart.Condie@wsj.com；@StuartLCondie)